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ABSTRACT
ECOLOGICAL MOMENTARY ASSESSMENT OF ANXIETY, DAILY STRESS,
AND DAILY GLYCEMIC CONTROL IN ADOLESCENTS WITH TYPE 1
DIABETES
Natalie E. Benjamin, M.S.
Marquette University, 2021
Type 1 diabetes (T1D) is an increasingly common chronic illness in children and
adolescents that can result in short- and long-term health complications. Adolescents with
T1D represent a uniquely vulnerable population, as both physical and psychological
disease outcomes tend to deteriorate during this period of development. Thus, among
adolescents it is crucial to gain further understanding of what psychological and
contextual factors promote optimal disease management. While traditional methods of
assessment in this population involve one-time, long-term measurements of psychosocial
factors and glycemic control, ecological momentary assessment (EMA), including daily
diaries, are increasingly used to capture change processes both between and within
individuals. The present study utilized EMA methods (daily diaries for seven days) to
explore associations between general stress (GS), diabetes-specific stress (DSS), and
glycemic control. Anxiety was measured at baseline and examined as a moderator.
Forty-four adolescents (ages 13-17) diagnosed with T1D were recruited from
diabetes summer camps. Participants completed the Revised Children’s Manifest Anxiety
Scale, 2nd Edition at camp. Daily diaries, including measures of GS and DSS, were
completed in the fall. Participants uploaded blood glucose values via Tidepool®, which
were used to calculate daily mean blood glucose values. Daily GS and DSS scores were
used to quantify both within- and between-subjects variance in each construct.
Multilevel model analyses revealed that increased within-subjects fluctuations in
daily DSS were predictive of poorer daily glycemic control. Conversely, betweensubjects variation in average levels of DSS across the measurement period did not play a
significant role in predicting mean daily blood glucose. GS levels were not predictive of
glycemic control at either level. Additionally, trait anxiety did not moderate the
association of fluctuations in daily DSS with glycemic control.
Overall, the association between fluctuations in daily diabetes-specific stress and
same-day glycemic control highlights the need for clinicians to focus on bolstering
adolescents’ adaptive responses to daily disease-related stressors. Additionally, this study
underscores the importance of examining both between- and within-person psychosocial
processes in individuals with T1D in order to fully understand the mechanisms
underlying disease management.
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Introduction
Type 1 diabetes (T1D) is one of the most prevalent chronic illnesses in the United
States. Currently, 1.25 million individuals are living with T1D, including an estimated
200,000 children and adolescents (Centers for Disease Control and Prevention, 2017).
With up to 18,000 new cases in youth annually, it is expected that by the year 2050 up to
600,000 children and adolescents will be living with the disease (Dabelea et al., 2014).
An autoimmune disease, T1D results when pancreatic cell destruction leads to insulin
deficiency, resulting in an inability to convert food and glucose into energy (Daneman,
2006). Because T1D is most often diagnosed in childhood or young adulthood, the
disease poses many inherent challenges to youth and their caregivers, including constant
disease monitoring and an often invasive treatment regimen. Poor disease management
may have serious short- and long-term consequences for physical health. Adolescents
represent a uniquely vulnerable population, as both physical and psychological disease
outcomes tend to deteriorate during this period of development (Garvey et al., 2012;
Hilliard et al., 2013). Additionally, adolescence is often the time when youth begin to
assume more responsibility for their own disease management, and they form habits that
are likely to carry into adulthood. Thus, among adolescents it is crucial to gain further
understanding of what psychological and contextual factors promote optimal disease
management.
There are many psychological factors whose associations with disease
management and glycemic control are well established in pediatric diabetes literature.
The emotional burden of living with and managing a chronic illness daily may lead to
internalizing symptoms, particularly depression. A wealth of existing research shows
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higher levels of psychological distress in adolescents with T1D when compared to their
healthy peers; additionally, increases in depressive symptoms are linked with poorer
glycemic control in teens with T1D (Buchberger et al., 2016; Hood et al., 2006). A metaanalysis of studies examining psychological distress among children and adolescents with
T1D as compared to their healthy peers revealed that those with T1D report significantly
higher levels of depressive symptoms, a higher frequency of clinical depression, more
anxiety, and more general psychological distress than the control group (Reynolds &
Helgeson, 2011). Health-related quality of life is poorer for youth with T1D, and it also
tends to deteriorate in adolescence (Graue et al., 2003). Stress may also negatively affect
adolescents’ ability to manage their disease. In addition to the general stress experienced
by healthy adolescents, youth with T1D experience diabetes-specific stressors that are
related to poor glycemic control (Helgeson et al., 2010). Optimal glycemic control
requires adolescents (and their caregivers) to adhere to a strict health regimen and to
successfully carry out a variety of regulatory tasks every day, which can cause stress
specifically related to completing out these tasks.
Historically, the study of psychosocial factors in the context of pediatric diabetes
has relied on one-time recall measurements. This approach, while logistically simple,
conflicts somewhat with psychologists’ interest in youths’ everyday, real-world behavior.
Ecological momentary assessment (EMA) refers to a range of assessment methods that
are naturalistic, ambulatory, and real-time (Heron et al., 2017). These methods have
many methodological advantages, including reduced recall errors and bias and increased
ecological validity (Smyth & Heron, 2014). EMA is particularly relevant to research
examining glycemic control and related factors in children and adolescents with T1D
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given the potential for daily fluctuations in individual characteristics and diabetes
management demands.
The present study will utilize EMA methods to examine relationships between
daily stress and daily blood glucose levels and the potential moderating role of anxiety.
Following a summary of basic information about T1D in adolescents, literature pertaining
to anxiety and stress in this population will be reviewed. The paper will then describe
existing research employing EMA methods with youth with T1D before discussing the
goals and approach of the present study.
The following terms will be used throughout this paper and must therefore be
defined. “Glycemic control” refers to typical levels of blood glucose in an individual and
is often used as a proxy for how well-controlled one’s diabetes is. “Adherence” or
“treatment adherence,” sometimes also referred to as “compliance,” will be used to
describe the degree to which youth follow typical medical advice for the management of
T1D (American Diabetes Association, 2020). Although the terms are sometimes
conflated in T1D research, it is important to note that “adherence” is a behavioral
construct while “glycemic control” refers to the physiological outcome. In this study,
glycemic control will be utilized as an objective physiological indicator of disease
management, with lower values corresponding to more successful management.
Type 1 Diabetes Management
For youth and adults with T1D, disease management involves an intensive
treatment regimen that often requires individuals to fit their lifestyle to their illness. To
compensate for the fact that the pancreas does not produce insulin, individuals with T1D
must monitor their blood glucose (BG) levels and administer insulin appropriately.
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Medical professionals encourage individuals with T1D to aim for BG levels similar to
those of healthy individuals. Glycemic control reflects the extent to which individuals
accomplish this, with lower numbers reflecting better control. Target BG levels for
children and adolescents vary slightly by age but generally range from 90 to 150 mg/dl
(American Diabetes Association, 2020). BG levels have traditionally been monitored
with multiple daily finger pricks. Continuous glucose monitors (CGMs), introduced in
2005, provide a glucose level once every five minutes, resulting in infinitely more data
than one receives from finger prick checks four to six times per day. The use of CGMs in
adolescents with T1D can significantly improve their glycemic control by providing
accurate data, promoting patient communication with medical providers, and enhancing
motivation to self-monitor blood glucose levels (Bergenstal et al., 2010; SchaepelynckBelicar et al., 2003). Recent data from the Type 1 Diabetes Exchange Registry suggest
that 17% of adolescents nationwide use a CGM, a number that increased significantly
between 2011 and 2016 (DeSalvo et al., 2018). Current recommendations include
considering CGM use for all children and adolescents with T1D (American Diabetes
Association, 2020).
Long-term glycemic control is measured with hemoglobin A1C (HbA1C), which is
an objective measure reflecting one’s average BG level over the past two to three months
(Gonder-Frederick & Cox, 1991). Values are expressed as percentages of hemoglobin
that is glycated (i.e., bonded to glucose). Recommendations from the American Diabetes
Association for target HbA1C levels are presented by age group, such that adolescents are
expected to meet similar requirements to adults (American Diabetes Association, 2020).
Achieving lower HbA1C levels, while ideal, also creates more frequent risk for
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hypoglycemia. Young children may also be less able to recognize physiological
symptoms of hypoglycemia; hence, children under 6 years of age have a target HbA1C
value of 7.5% to 8.0%. Adolescents are told to aim for a value under 7.5% given the
higher risk of poor glycemic control leading to complications post-puberty.
Physiological Complications of T1D
Poor glycemic control can have severe short- and long-term consequences for
individuals with T1D. Without (and sometimes even with) close daily attention to BG
levels and insulin administration, inconsistent out-of-range BG levels can lead to shortterm physiological symptoms and above-target HbA1C levels in the long term. In the
moment, low BG levels can cause immediate symptoms including shakiness, sweating,
irritability, confusion, rapid heartbeat, dizziness, hunger, and weakness (American
Diabetes Association, 2020). High BG levels can lead to thirst, frequent urination,
headaches, nausea, and diabetic ketoacidosis, which is a life-threatening condition in
which the body breaks down fat and muscle for energy due to a lack of available insulin
(Wolfsdorf et al., 2006). Long-term complications of T1D typically result from
chronically high BG levels, as symptoms of hyperglycemia are easier to ignore or
habituate to. Immediate symptoms of low BG are disruptive and often incapacitating;
thus, hypoglycemia is often treated immediately. That said, extremely low BG levels can
result in seizures and loss of consciousness, especially in children and other individuals
unable to recognize early symptoms of hypoglycemia. T1D reduces the typical lifespan
by 11 to 13 years and significantly increases the risk of heart disease and stroke
(Livingstone et al., 2015). Kidney damage is a common long-term complication and leads
to complete kidney failure over time in approximately 30% of patients with T1D
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(National Kidney Foundation, 2015). Neuropathy in the feet and other extremities is also
common. T1D is the leading cause of both blindness and lower limb amputations in the
U.S. every year (American Diabetes Association, 2020).
T1D in Adolescence
In addition to the many inherent management challenges of T1D at any age,
adolescents must also grapple with developmental challenges that occur during this
period. Adolescence is a pivotal time for T1D management, especially as caregiver
involvement tends to decrease and adolescents take on increasing responsibility (Hanna
& Guthrie, 2003). Adolescence is a period of rapid biological development and
increasing emotional, cognitive, and physical maturity that is often characterized by
teens’ search for autonomy and independence from caregivers (Herzer & Hood, 2010).
Moreover, hormonal development can trigger changes in insulin sensitivity related to
physical growth and sexual maturation and may also result in a neurological vulnerability
to hypoglycemia and hyperglycemia (Barnea-Goraly et al., 2014). More than half of
youth with T1D do not meet the glycemic control guidelines prescribed by their
endocrinologists (Amed et al., 2013). A wealth of research with adolescents shows steady
increases in HbA1C levels throughout adolescence, often plateauing at high levels around
the age of 17 and remaining high through young adulthood (e.g., Clements et al., 2016).
During childhood, T1D management tasks are primarily the responsibility of
caregivers. During adolescence, this responsibility begins to transfer to the youth in
preparation for adulthood. This transition period can be one of the most difficult times for
adolescents with T1D (Garvey et al., 2012). Because adolescents are physically able to
complete adherence tasks, parents may be tempted to quickly hand all responsibility to
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their children. However, while adolescents may be physically prepared for the increased
responsibility, they often need help with the decision-making and planning required to
execute T1D tasks successfully (Herzer & Hood, 2010). This may leave youth feeling
unsupported and vulnerable, which can result in an avoidance of self-care and follow-up
care from medical providers. Reduced parental monitoring and poorer communication,
together with an increase in time spent outside the home (e.g., more extracurricular
activities and less predictable schedules), are often associated with declines in adherence
(Amed et al., 2013; Hilliard et al., 2013; Rustad et al., 2013). Conversely, caregivers may
be hesitant to relinquish control over daily management tasks. This may result in a
frustrating dynamic in which adolescents wish for autonomy that caregivers are unwilling
to give. These unpredictable caregiver-adolescent dynamics are often related to poor
glycemic control (Anderson et al., 2009).
Of course, it is not the case that adherence and glycemic control decline
universally across individuals. A multitude of physiological, psychological, and
contextual factors affect adolescents’ ability to manage the many adherence tasks
involved in maintaining optimal glycemic control. A longitudinal study of over one
thousand youth with T1D found that significant deteriorations in glycemic control
occurred over the first six years after diagnosis for adolescents. Moreover, psychosocial
burden was a specific contributor to these suboptimal glycemic outcomes (Hood et al.,
2014). The following section will review research examining specific psychosocial
factors that are associated with adherence and glycemic control in adolescents.
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Psychosocial Factors Related to Adherence in Adolescents with T1D
Research has documented that a wide variety of psychosocial factors are related to
adherence behaviors, and glycemic control by extension, in adolescents with T1D. Some,
such as negative mood and affect, have been researched for years; others have been
explored only more recently. Before exploring how psychosocial factors fluctuate on a
daily basis in this population, it is necessary to thoroughly review the research exploring
global relationships between these factors and adolescents’ ability to complete
management tasks and glycemic control.
Anxiety
Negative mood and affect have long been established as psychological factors
with a reliable relationship to both adherence and glycemic control in individuals with
T1D. Depression and anxiety both stand out as internalizing syndromes that are prevalent
in this population. An early study of youth with diabetes showed that nearly 50% of
adolescents were diagnosed with a psychiatric disorder within 10 years of their T1D
diagnosis, and chief among them was depression (Kovacs et al., 1997). Hood and
colleagues (2006) found that nearly one in seven youth with T1D report clinically
significant symptoms of depression, which is nearly double the highest estimates of rates
in the general adolescent population. Although specific rates vary between studies based
on methods of measurement, an abundance of research has reported concerning rates of
internalizing symptoms in adolescents with T1D.
Anxiety is a leading concern in this population. Silverstein and colleagues (2005)
reported that over 18% of youth with T1D are diagnosed with an anxiety disorder at some
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point during their childhood or adolescence, and a more recent study found that a similar
proportion (21.3%) of their sample screened positive for an anxiety disorder (Bernstein et
al., 2013). Additionally, relationships between increased anxiety symptoms and poorer
adherence and glycemic control are well documented (e.g., Herzer & Hood, 2010). A
recent meta-analysis confirmed that a high proportion (i.e., 32%) of adolescents with
T1D report symptoms of anxiety, and that these symptoms are associated with poorer
glycemic control (Buchberger et al., 2016). Trait (i.e., baseline) anxiety has been
associated with increased fear of hypoglycemia, increased rates of hypoglycemia,
decreased rates of BG monitoring, and poorer ability to distinguish between physiological
symptoms of anxiety and hypoglycemia (Rechenberg, Whittemore, & Grey, 2017).
The directionality of the relationship between anxiety and poor glycemic control
is unclear. Some work shows that diabetes-related worries negatively impact adherence
and glycemic control (e.g., Mortensen, 2002; Naar-King et al., 2006). Conversely,
Gonder-Frederick and colleagues (2006) found that a history of hypoglycemic episodes
predicts current diabetes-related stress and anxiety, implying that poor glycemic control
in the past impacts current anxiety about diabetes. Thus, it is not clear whether poor
glycemic control elicits anxiety or if the opposite is true; the relationship is likely
bidirectional. Herzer and Hood (2010) examined the prevalence of internalizing
symptoms in adolescents with type 1 diabetes and associations between anxiety and
glycemic control in this population. In congruence with prior research, results indicated
that adolescents experiencing higher levels of both state and trait anxiety and higher
levels of depression checked their BG less frequently per day and had poorer long-term
glycemic control. Thus, it is possible that symptoms of anxiety may interfere with
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adolescents’ ability to complete adherence tasks, negatively impacting glycemic
outcomes. Conversely, the daily demands and variable outcomes of T1D disease
management may contribute to increase symptoms of anxiety in these youth. However,
the specific mechanisms of the relationship between anxiety and glycemic control, and its
negative impact on the health of these youth, are poorly understood.
General and Diabetes-Specific Stress
Stress has also been explored as a factor that plays a role in adolescents’ glycemic
control. Adolescents in the U.S. report general stress at rates equal to or higher than their
adult counterparts (American Psychological Association, 2018). Primary stressors in this
age group include gun violence, the political climate, money, and health-related concerns.
For adolescents with T1D, the disease diagnosis is a significant additional stressor.
Helgeson and colleagues (2010) conducted a longitudinal study and found that frequency
of stressful life events predicted psychological distress, poorer self-care behavior, and
poorer glycemic control. These associations were stronger among older adolescents (e.g.,
ages 15-17) than younger ones (e.g., ages 11-14).
Not all stress is created equal, especially for individuals with chronic illnesses.
The distinction between general stress (GS) and diabetes-specific stress (DSS) is an
important one when exploring diabetes-related outcomes such as adherence and glycemic
control. Adolescents and parents report frequent problems related to hyperglycemia or
hypoglycemia, forgetting to check their BG levels, and leaving supplies at home
accidentally (Beveridge et al., 2005; Fortenberry et al., 2012). DSS as a construct thus
focuses on stress related to these diabetes-specific problems. This distinction between GS
and DSS is an especially important one given past research showing that diabetes-specific
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stress is uniquely related to poor diabetes outcomes (Farrell et al., 2004). Chao et al.
(2016) explored general and diabetes-related stressors in adolescents with T1D and found
that the vast majority of teens reported school as a top stressor, followed by social life,
and diabetes. Diabetes stressor themes included having diabetes, dealing with emotions
related to diabetes, and diabetes management.
Although Chao and colleagues noted that teens perceived GS more frequently
than DSS, related research has shown that DSS is uniquely related to poor glycemic
control. Farrell and colleagues (2004) explored both perceived GS and perceived DSS
and their respective associations with adherence behaviors and glycemic control (i.e.,
HbA1C). Results revealed that greater DSS was directly related to higher HbA1C (i.e.,
poorer glycemic control), while greater GS was only indirectly associated with higher
HbA1C via poorer adherence behaviors. Conversely, DSS was not related to adherence
behaviors, which led the authors to conclude that GS may be more disruptive to daily
routines given that it involves multiple domains of adolescents’ lives. Hagger and
colleagues (2016) conducted a systematic review of “diabetes distress” in adolescents,
which they defined as negative emotions that arise from living with T1D. While this
construct likely includes more than just DSS, researchers found that associations between
“diabetes distress” and HbA1C were strongest when distress was assessed with the
Diabetes Stress Questionnaire (Berlin et al., 2012), which specifically measures DSS.
This finding implies a close relationship between DSS and glycemic control.
Additional research has underscored the nuances of DSS experienced by this
population and implications for health-related outcomes. Berlin, Rabideau, and Hains
(2012) examined patterns of subtypes of perceived DSS among youth with T1D. Three
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pattern profiles of perceived DSS emerged including low stress, interpersonal/peer stress,
and family stress. The group of adolescents who reported family stress as primary also
had significantly higher HbA1C values than adolescents who reported experiencing
primarily the other two types of DSS. These results are consistent with what is known
about diabetes-specific family conflict and the potential for turmoil during adolescence as
responsibility for disease management transitions from caregiver to teen (Williams et al.,
2009). This research highlights the fact that global measures of stress may not sufficiently
account for associations between perceived stress and glycemic control. Thus, it is
important to account for adolescents’ perceptions of their diabetes-specific stress and
appraisal in order to promote optimal disease management.
Taken together, the results of the studies reviewed here indicate that both anxiety
and stress have important, established relationships with adherence and glycemic control
in adolescents with T1D. Although in most cases directionality has yet to be established,
it is clear that poor psychosocial functioning has negative implications for diabetes
management in this population. The majority of the studies reviewed thus far have
utilized one-time recall measurements of all variables. While studies using these
approaches are crucial to the establishment of global relationships between psychosocial
factors and diabetes-related outcomes in this population, the following section will
review studies that employ more nuanced, ambulatory approaches to explore these
relationships further.
EMA as a Methodology
Behavioral scientists aim to study human behavior, thoughts, and emotions in
ways that allow them to draw conclusions about participants’ everyday real-world
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experiences. However, such behaviors, thoughts, and emotions are most often studied in
the context of a lab, hospital, or other artificial setting that bears many distinctions from
individuals’ typical lives. Such approaches arose out of a desire to control the experiences
of participants; however, in doing so, researchers often render findings ungeneralizable to
other settings. Furthermore, individual experiences are often studied globally via onetime recall self-reports that ask participants to report on a summarized experience over a
long period of time (e.g., level of anxiety over the past six months), which introduces the
potential for recall bias (Shiffman et al., 2008). Psychological research often asks
participants to summarize their experiences over a period of time (e.g., “how intense was
your pain over the past month?”). The longer this period of time, the more participants
rely on cognitive heuristics to estimate a response (Margetts et al., 2003). In psychology
especially, it is important to focus on short-term reports in order to understand how
thoughts, feelings, and behaviors may vary over brief periods of time. Many psychosocial
factors undergo dynamic changes from day to day or from moment to moment.
Psychological researchers’ reliance on one-time recall data fails to consider such realworld, dynamic processes. It is crucial to examine data on a more immediate level in
order to better understand the mechanisms underlying global patterns that have been
observed.
“Ecological momentary assessment” does not refer to one single method of data
collection, but rather to a range of assessment methods that are naturalistic, ambulatory,
and real-time (Heron et al., 2017). These methods include daily diaries (both paper/pencil
and electronic), experience sampling, and ambulatory monitoring of physiological
parameters. EMA as a group of methodologies can be especially helpful in answering
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research questions relating to the impact of environmental or situational factors (e.g.,
comparing adherence behaviors at school and at home); natural day-to-day fluctuations in
thoughts, feelings, or behaviors; or the impact of internal factors (e.g., relationships
between daily stress and adherence behaviors). EMA emerged fairly early in the history
of behavioral research, as many behavioral scientists designed studies asking participants
to record information about their subjective experiences (e.g., behaviors, thoughts,
emotions, social interactions) over time (Shiffman et al., 2008). EMA was also used early
in the field of health psychology as a way of checking the accuracy of health-related selfreport data about illness episodes (Thiele et al., 2002).
EMA is an increasingly popular method of data collection in the social and health
sciences, including with child and adolescent populations, and it holds many advantages
for behavioral researchers. The administration approach allows participants to complete
surveys and diaries in a naturalistic setting; often participants complete measures on a
home computer or mobile phone, or they are given paper-pencil measures to fill out over
the course of a week or month. Researchers using EMA recognize that many behaviors
and experiences are influenced by the environment, and thus it is imperative to sample
behaviors and experiences in the context in which they typically occur (Shiffman et al.,
2008). This increases the ecological validity of collected data.
Unfortunately, all self-reported data is subject to recall biases that threaten their
validity. Additionally, recall bias is not evenly distributed; rather, it is systematic in
nature. For instance, individuals are more likely to recall negatively-valenced information
when they are experiencing negative moods (Hassan, 2005). Furthermore, recall depends
on memory, which can be notoriously unreliable in many ways. Details of an event may

15
not be noticed and therefore not stored in memory. Additionally, memory distorts recall
even after relatively short intervals, and repeated retrieval of the same memory may lead
to further distortions or additional information being stored (Bradburn et al., 1987). By
asking participants to reflect on the past day (or the past few hours), as opposed to a
longer period of time, EMA researchers decrease the likelihood of errors in memory. This
is especially relevant to psychological research, in which researchers often ask
participants to summarize their experiences over a period of time (e.g., “how intense was
your pain over the past month?”).
The intensive nature of EMA data collection also allows for a reduction of the
recall period, which may increase the validity of participants’ responses. This advantage
is particularly relevant when conducting research with children and adolescents, who may
face increased struggles in accurately reporting on behaviors and experiences as
compared to adults (Heron et al., 2017). Specific to pediatric populations, youth may be
better able to report on subjective experiences of pain and sensation, treatment adherence,
sleep, and psychological symptoms across shorter time periods. Lastly, EMA data
collection yields intensive longitudinal data, or data with repeated measurements over a
relatively short time period, which allow for the examination of within-subject changes in
behavior and experience over time and across contexts (Shiffman et al., 2008).
Disadvantages of EMA approaches are few but not insignificant. EMA
approaches are inherently time-intensive, as they require the repeated assessment of the
same subjects. This challenge highlights the appeal of bringing participants to the lab to
complete various one-time measures and is likely a leading reason of why EMA
approaches, while more comprehensive, are not a default methodology. Researchers must
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determine how best to administer such assessments repeatedly to participants in their
homes. Paper diaries, while simple to create, may nevertheless be problematic when
participants must report times of day at which they are completing measures. Electronic
diaries will record times automatically, which is important given that studies have shown
many individuals are not truthful when reporting times of day (Clifford et al., 2014).
Electronic diaries, however, are not always financially feasible. Many of the most
successful EMA studies involved researchers giving participants phones or small tablets
to use over the course of the EMA period, which may come at a significant economic
cost. Despite the price, Hufford and Shields (2002) argued for the development and use
of electronic diaries, citing poor data quality and suboptimal compliance with paper
diaries.
EMA and Type 1 Diabetes
EMA methodologies are particularly relevant to research examining the
management of life with T1D. In addition to daily variation in psychosocial factors,
youth with T1D experience moment-to-moment fluctuations in their physiology (e.g.,
blood glucose levels). These fluctuations are likely to be accompanied by physiological
symptoms that may interact with psychosocial factors over the course of a day.
Additionally, the gold-standard measure of glycemic control, HbA1C, is an oversimplified
global measure of a factor that fluctuates daily, even from hour to hour. Using HbA1C, an
average of three months’ worth of BG values, does not consider daily, weekly, or even
monthly variation that is crucial to the understanding and improvement of glycemic
control. Additionally, two individuals may have the same HbA1C value over one threemonth period but wildly different BG values during that same period; this would have
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important implications for potential diabetes-related physiological complications.
Unfortunately, HbA1C alone may not be the best predictor of later complications.
Analysis of data from the Diabetes Control and Complications Trial revealed that blood
glucose variability adds to the risk of microvascular complications from diabetes, above
and beyond that predicted by HbA1C value alone (Kilpatrick et al., 2008). Although low
BG value will bring down one’s average BG level, a low BG value does not counteract
the damage done by a high BG value (and may in fact lead to its own complications).
Thus, the importance of examining day-to-day adherence and glycemic control is evident.
As has been reviewed in previous sections, there exists a wealth of research
establishing relationships between myriad psychosocial factors and glycemic control in
adolescents with T1D. However, the literature reviewed thus far has exclusively
examined relationships between HbA1C and psychosocial variables as measured by onetime recall assessments. More recently, research has begun to examine how some of these
psychosocial variables vary on a daily basis and the relationship between those variations
and individuals’ daily BG values.
Specifically, 11 studies have been conducted with adolescents with T1D utilizing
EMA methods. The studies employed a variety of data collection methods (see Table 1).
Across these studies, those with the highest rates of participant compliance were those
that utilized once daily online surveys for up to two weeks, provided small incentives for
each completed diary, and contacted participants nightly with reminders or problemsolving help. These methods were not only the most successful, but they were the most
popular among the 11 EMA studies reviewed here. These methods appear feasible and
successful with children and adolescents as young as 10 years old. It is likely that the
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flexibility of the once daily online survey leads to such high compliance rates;
adolescents may have benefitted from being able to complete surveys at home in the
evening, which also provided parents the opportunity to remind them about participation.
Two exemplary studies (i.e., Baucom et al., 2015; Lansing et al., 2016) utilizing
EMA methods to great effect in this population explored relationships between daily
psychosocial functioning and daily BG levels, in addition to examining the role of
baseline trait characteristics (i.e., self-control and depression, respectively). Lansing and
colleagues (2016) explored what individual processes link daily self-regulation with daily
BG levels and the moderating role of self-control. Participants completed a baseline
measures of self-control and adherence, followed by 14 consecutive days of daily diary
measures of negative affect about diabetes and number of diabetes problems experienced.
During this 14-day period, adolescents monitored their BG levels using meters provided
by researchers. Adolescents with higher baseline self-control experienced less negative
affect on days when they had many diabetes problems. Higher baseline self-control was
also related to lower mean BG values and less BG variability. These results support
previous findings that self-control facilitates effective affect regulation and enables better
diabetes care, which emphasizes the role of multiple aspects of self-regulation in optimal
daily diabetes care.
Given established findings that depressive symptoms are increased in youth with
more poorly controlled diabetes, researchers have examined to what extent depressive
symptoms might account for poor adherence in the short term, with the presumption that
this may be the mechanism contributing to poor long-term glycemic control. Baucom and
colleagues (2015) explored relationships between daily stress, depressive symptoms, and

19
daily adherence in adolescents with T1D and the possible moderating role of depressive
symptoms on the relationship between stress severity and daily adherence. Researchers
also distinguished between general stress and diabetes-specific stress. Again, participants
completed baseline measures, followed by a 14-day diary of both GS and DSS severity
and adherence. Not only did this sample report high levels of depressive symptoms, but
these depressive symptoms were associated with more severe daily stress, poorer daily
adherence, and poorer glycemic control. Adolescents reported poorer adherence on days
with more severe DSS, which emphasizes the unique role of specific stress on
adolescents’ ability to complete adherence tasks each day. Additionally, adolescents high
in depressive symptoms and high in DSS showed an association between daily DSS and
adherence behaviors. Hence, among adolescents with T1D, the combination of more
severe depressive symptoms and high daily DSS may make it particularly challenging to
manage one’s diabetes.
In summary, researchers have utilized EMA methods and the resulting intensive
longitudinal data to establish relationships between daily psychosocial processes and
glycemic control in adolescents with T1D. Additionally, researchers in this area have
emphasized the value of combining moment-to-moment assessment of psychosocial
variables with data from advancing blood glucose monitoring technology (i.e.,
continuous glucose monitors) in order to examine how within-day fluctuations in
psychosocial processes relate to BG values at the same times.
Importantly, no study to date has examined relationships between daily stress,
anxiety, and glycemic control in adolescents. Aikens and colleagues (1992) explored
relationships between daily GS and HbA1C in adults with T1D and found that individuals
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with greater fluctuations in daily GS severity had higher HbA1C levels. It is not currently
known if adolescents with T1D exhibit similar daily stress and glycemic control patterns
as adults, whether this pattern is the same for both GS and DSS, or whether anxiety plays
the same moderating role as does depression in this equation (Baucom et al., 2015).
Given the many daily stressors (both general and diabetes-specific) in the lives of
adolescents with T1D, it is crucial to explore the psychological and physiological effects
of stress on this population and furthermore to determine the characteristics of youth who
are most susceptible to daily fluctuations in stress.
Present Study Overview and Hypotheses
Given the nature of T1D management and the possibility for daily fluctuations in
emotions, stressors, and diabetes-related outcomes, the current study examined
relationships among stress and glycemic control on a daily level and the potential
moderating role of trait-level (i.e., baseline) anxiety. This study measured participants’
anxiety at baseline and utilized EMA methods to measure daily fluctuations in general
and diabetes-specific stress. Additionally, BG data for the same period was collected in
order to evaluate relationships between the psychosocial factors listed above and
individuals’ daily glycemic control. Daily BG data were averaged to create a mean blood
glucose (MBG) value for each day of the EMA period, which was used as a measure of
daily glycemic control. Aims and hypotheses for the present study included the
following:
Aim 1: To explore between- and within-person associations between daily stress (i.e.,
general and diabetes-specific) and daily glycemic control among adolescents with
T1D.
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Hypotheses:
1a. Adolescents will exhibit higher MBG levels on days when DSS fluctuates to a
greater level than their respective averages.
1b. Adolescents who report higher mean levels of DSS across days will exhibit
higher MBG levels across days.
1c. Adolescents will exhibit higher MBG levels on days when GS fluctuates to a
greater level than their respective averages.
1d. Adolescents who report higher mean levels of GS across days will exhibit
higher MBG levels across days.
Aim 2: To examine whether between-person differences in baseline anxiety levels
moderate each of these associations.
Hypotheses:
2a. Adolescents who report higher levels of baseline anxiety will experience
larger increases in MBG on days when they report higher DSS than their average
DSS, as compared to adolescents who report lower levels of baseline anxiety.
2b. Adolescents who report higher levels of baseline anxiety will display a
stronger positive association between overall DSS and MBG than adolescents
who report lower levels of baseline anxiety.
2c. Adolescents who report higher levels of baseline anxiety will experience
larger increases in MBG on days when they report higher GS than their average
GS, as compared to adolescents who report lower levels of baseline anxiety.
2d. Adolescents who report higher levels of baseline anxiety will display a
stronger positive association between overall GS and MBG than adolescents who
report lower levels of baseline anxiety.
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Research Design and Method
Participants
Participants in this study included 44 adolescents aged 13 to 17 years with a
current diagnosis of type 1 diabetes for more than one year. Potential participants with a
diagnosis of type 2 diabetes were excluded from the study. Adolescents who participated
in a pilot version of this study in previous summers were eligible for recruitment. A priori
power analyses indicated that 42 subjects would be necessary in order to have 80% power
to detect a medium effect size for all hypothesized direct effects at .05 criterion of
statistical significance.
A total of 79 participants from two field sites were recruited for this study and
completed baseline measures: 52 from the California site and 27 from the Nevada site.
Participants from each site were compared on demographic variables (e.g., age at testing,
age at diagnosis, race/ethnicity), pump status, CGM status, and RCMAS-2 score.
Participants from the California site were older than those from the Nevada site, t(77) =
3.23, p = .002. No other significant group differences were observed.
Forty-four of the 79 recruited participants completed some or all of the daily
surveys. Participants who completed daily surveys were compared to those who did not
on demographic variables, pump status, CGM status, and RCMAS-2 score. Subjects who
used a CGM were more likely to complete daily surveys than those who do not use a
CGM, c2 = 7.289, p = .007. No other significant group differences were observed. There
were no significant differences in daily survey completion between the two sites, c2 =
1.06, p = .30. Five participants completed one daily survey, two completed two surveys,
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one completed three surveys, two completed four surveys, two completed five surveys,
and 32 completed all seven surveys.
Of the 44 participants who completed daily surveys, 25 uploaded BG data to
Tidepool®. Participants who completed uploads were compared to those who did not on
demographic variables, pump status, CGM status, RCMAS-2 score, and mean GS and
DSS severity. Girls were significantly more likely than boys to complete an upload, c2 =
6.68, p = .01. No other significant group differences were observed.
Procedure
Participants were recruited from diabetes camps located in California and Nevada
in the summer of 2019. Parents of children who were registered for camps hosted by the
Nevada Diabetes Association and Diabetes Youth Families were emailed information by
the camp directors about the study and the investigators prior to the start of camp.
Families interested in participating completed online parent permission forms. In-person
recruitment also took place immediately before the start of each camp.
Adolescents whose parents gave permission for their participation gave written
assent before proceeding with study procedures. For each stage of data collection they
completed, participants were entered to win one of three $25 gift cards.
Following individual assent, participants completed an initial survey of baseline
anxiety on an iPad (Stage 1). Following camp, participants were contacted and asked to
complete seven daily surveys assessing general and diabetes-specific stress (Stage 2).
This occurred in the fall when participants had returned to school and other typical
activities in order to increase the ecological validity of the data. Participants were
intentionally asked to participate after their first week back at school in order to capture a
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representative school week. Weeks with school holidays (e.g., Labor Day) were also
avoided when possible. The survey period began on Monday and ended on Sunday.
Surveys were sent each day via email or text message to either the participant or their
caregiver, depending on participant preference. Daily reminders were sent to participants
if they had not completed the survey by an agreed-upon time of day. After this period of
daily diary completion, participants were asked to upload their BG data (Stage 3), which
included BG data concurrent with the daily survey period. BG data were uploaded via
Tidepool®, which is an open-source, FDA-approved website that allows researchers to
access patient data.
Measures
Revised Children’s Manifest Anxiety Scale – Second Edition (RCMAS-2)
The RCMAS-2 (Reynolds & Richmond, 2008) is a 49-item self-report measure of
anxious thoughts, feelings, and behaviors (see Appendix A). Questions are presented in a
simple yes/no format, and adolescents typically spend 10 minutes or less completing the
measure. Individual item scores are used to calculate a total anxiety score in addition to
subscales scores of physiological anxiety, worry, and social anxiety. Subscale scores
were determined by a factor analysis of the full reference sample of 3,086 U.S. children
and adolescents (Reynolds & Richmond, 2008).
The RCMAS-2 (and previous versions of the measure) have been used to assess
anxiety in adolescents with T1D (Helgeson & Novak, 2006; Kamps et al., 2005) and
adolescents with various chronic illnesses (Houck et al., 2006). A meta-analysis of
anxiety in children with chronic illnesses found that ratings of anxiety using the RCMAS
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in this population were similar to those on other well-validated measures (e.g., Behavior
Assessment System for Children, State-Trait Anxiety Inventory for Children; Pinquart &
Shen, 2011). In the current sample, internal consistency for the full scale as measured by
Cronbach’s alpha was good (a = 0.87). In the present study, total anxiety score T-scores
(mean score of 50, standard deviation of 10) were used for analyses.
Demographics
Adolescents were asked to report on date of birth, diabetes diagnostic status, age
of diagnosis, gender, grade in school, race, ethnicity, and pump/CGM status (see
Appendix B). Demographic variables were collected to describe the sample and were
used to assess for potential group differences.
Daily General Stress (GS)
Participants completed a checklist of five daily events related to general stress
(i.e., argument or disagreement with someone, problem with school or schoolwork,
problem with work or chores, having to deal with other people’s problems, and problem
related to where they live or things they own; see Appendix C). These items were adapted
by Baucom and colleagues (2015) from the Daily Inventory of Stressful events (Almeida
et al., 2002). Participants indicated whether they experienced each stressful event that day
and how stressful each endorsed event was on a scale of 1 (not stressful at all) to 5 (as
stressful as it can get). For each event endorsed, adolescents also indicated whether it was
related to their diabetes. This was rarely the case for these general stress events: argument
or disagreement with someone (18.8%), problem with school or schoolwork (15.8%),
problem with work or chores (40.0%), having to deal with other people’s problems

26
(4.3%), problem related to where they live or things they own (40.0%), broadly
consistent with previous research utilizing this measure (Baucom et al., 2015). Overall,
18.2% of general stress events were related to diabetes. Daily general stress (GS) severity
was calculated by taking the sum of the ratings across general stressors endorsed, divided
by the number of total items (i.e., five). Thus, items that were not experienced were
accounted for with a rating of zero. No prior reliability information is available for this
measure. Previous research using this scale has revealed relationships between daily GS
and depressive symptoms (Baucom et al., 2015).
Daily Diabetes-Specific Stress (DSS)
Participants completed a checklist of five daily events related to diabetes-specific
stress (i.e., problem with high/low blood sugar, forgetting or skipping a BG test, taking
the wrong amount of insulin, feeling bad because of diabetes, and problem with pump or
CGM; see Appendix C). These items were developed by Baucom and colleagues (2015)
from coding of open-ended descriptions of mother- and adolescent-reported diabetes
events (Beveridge et al., 2005). Participants indicated whether they experienced each
stressful event that day and how stressful each endorsed event was on a scale of 1 (not
stressful at all) to 5 (as stressful as it can get; Baucom et al., 2015). Daily diabetesspecific stress (DSS) was calculated by taking the sum of the ratings across diabetes
stressors divided by the number of total items (i.e., 5). Thus, items that were not
experienced were accounted for with a rating of zero. No reliability information is
available for this measure. Previous research using this scale has revealed relationships
between daily DSS, glycemic control, and depressive symptoms (Baucom et al., 2015).
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Daily Glycemic Control
Participants were asked to report their daily BG values. Previous studies
comparing self-reported BG values with meter downloads have found no significant
differences between values (Herzer & Hood, 2010; McGrady et al., 2009), and selfreported BG values have been solely used in past EMA studies with this population (e.g.,
C. A. Berg et al., 2014). BG data collected varied depending on participants’ technology
and device usage. Participants who check their BG values with meters were asked to
report all BG values for the given day, in addition to corresponding time stamps.
Participants who use a CGM were asked to report their BG levels for the current day at
the following times: 6:00 am, 9:00 am, 12:00 pm, 3:00 pm, 6:00 pm, and 9:00 pm (if
applicable). Daily BG values were averaged to generate daily mean blood glucose
(MBG) values and daily standard deviation of blood glucose values (SDBG).
Blood Glucose Data Uploads
Participants were asked to upload blood glucose data (from a meter or a CGM) for
the seven days for which they completed daily diaries to a secure website using
Tidepool®. Information about devices used by each participant was gathered at
recruitment. Private accounts were created for each participant that could only be
accessed by the research team. Participants were sent instructions specific to their devices
and were provided with technical support as needed.
Preliminary Analyses
Multilevel model analyses, conducted through SPSS v.25.0, were utilized to allow
for use of intensive longitudinal data and simultaneous consideration of between- and
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within-subjects effects. Missing data were accounted for using full information maximum
likelihood. Therefore, all data points (i.e., individual daily surveys) were included in the
dataset regardless of how many of the seven daily surveys each participant had
completed. Separate variables were calculated to quantify between- and within-subjects
variance of daily diary predictor variables. Specifically, mean GS and DSS severity were
calculated as each participant’s average score on each respective scale across all seven
diary days. These values were also grand mean centered. Within-subjects variance in GS
and DSS severity (i.e., daily fluctuations in GS and DSS severity) were calculated by
subtracting each participants’ mean score on that scale from their score for each diary day
(i.e., person centering). For any analysis that included GS or DSS severity, both mean
severity and daily fluctuations in severity were entered simultaneously in order to account
for both types of variance separately. In all models, time (i.e., day 1, day 2, day 3, etc.)
was accounted for but was not a significant predictor.
BG data were used to create two BG-related outcome variables: mean BG values
(MBG) were calculated by averaging participants’ BG levels each day; standard
deviation of BG (SDBG) was calculated as the standard deviation of participants’ BG
levels each day. These daily outcome variables were entered into models as single, nontransformed variables that contain both between- and within-subjects variance. Gender,
age at diagnosis, and pump status were considered as covariates given that these variables
have known associations with glycemic control (Palmer et al., 2004). There was minimal
variability in the pump status variable (i.e., 93% of the sample reported using a pump)
and thus the decision was made to exclude it from further analyses. Gender and age at
diagnosis were entered into all models as covariates.
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To examine between- versus within-subjects variance in daily diary measures,
intraclass correlation coefficients (ICCs) were calculated for DSS and GS severity, MBG
values, and SDBG values across the measurement period. ICCs indicated that 44% of the
variation in DSS severity, 33% of the variation in GS severity, 56% of the variation in
MBG, and 42% of variation in SDBG was between-subjects.
Blood Glucose Values
In the final sample of 44 participants, 25 (56.8%) completed BG data uploads via
Tidepool®. All participants provided self-report BG values. In order to explore the
accuracy of self-reported BG values, these values were compared to Tidepool® BG
values for participants who provided BG data uploads (n = 25). Self-reported BG values
were separated into between- and within-subjects variance and regressed onto Tidepool
BG values (both MBG and SDBG, respectively). Results indicated that, for MBG, the
model was significant, F(2, 157) = 113.63, p < .001, and both average self-reported MBG
across the week, B = 0.91, SE = .07, p < .001, and fluctuations in self-reported MBG, B =
0.59, SE = .07, p < .001, were associated with Tidepool® MBG. Similarly, for SDBG, the
model was significant, F(2, 156) = 37.97, p < .001, and both average self-reported SDBG
across the week, B = 0.85, SE = .13, p < .001, and fluctuations in self-reported SDBG, B
= 0.38, SE = .06, p < .001, were associated with Tidepool® SDBG. Thus, it was
concluded that self-reported BG data in this sample were reasonably accurate. For all
main analyses reported here, Tidepool® BG data were used when available (n = 25) due
to their objectivity and increased accuracy, and self-reported BG data were used for all
other participants (n = 19). Notably, all models presented in the Results section were also
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run using a) only Tidepool® data for those who had it, and b) only self-report data for all
participants, and the same pattern of results was found in all cases.
Pilot Testing
Pilot testing for the present study was conducted in order to assess feasibility of
the current data collection method. Fifty participants between the ages of 11 and 17 were
recruited from Nevada camps. All participants completed baseline measures at camp.
Two months later, all 50 participants were contacted for follow-up. Twenty-nine (58%)
responded and agreed to complete five days of EMA measures. Daily reminders were
sent as described in the procedure section above. Over the five-day period, 28
participants completed at least one daily diary. Following the EMA period, those 28
participants were asked to upload BG data. Six participants completed the upload. No
incentives were offered for any stage of data collection.
Results of pilot testing suggest that adolescents and their parents are generally
willing to enroll in studies with no offer of incentives and complete baseline measures at
the time of recruitment. However, motivation to complete later stages of data collection
may have decreased as time passed from recruitment. Thus, in the present study,
incentives were offered after each stage in order to increase the likelihood that
participants will complete all stages of data collection. The EMA period was lengthened
from five to seven days, and nightly reminders were again sent to participants and/or their
parents.

31
Results
Tables 3 and 4 present descriptive statistics for key study variables and
correlations among these variables. Bivariate correlations were conducted between mean
levels of DSS severity, GS severity, MBG, and SDBG values (i.e., averaged across the
seven-day measurement period) and RCMAS scores. Adolescents with higher mean DSS
severity were also more likely to report higher mean GS severity. Mean MBG and mean
SDBG were positively correlated.
Average anxiety symptom scores in the present study were below the suggested
clinical cutoff (i.e., T-score of 60), but 25% of the present sample (n = 11) scored in the
subclinical or clinically significant range. This finding is broadly consistent with prior
research indicating relatively high levels of trait anxiety in adolescents with T1D as
compared to their health peers (Buchberger et al., 2016). Adolescents who reported
higher anxiety at baseline also experienced higher average levels of DSS severity across
the measurement period.
Relationships Between Diabetes-Specific and General Stress Severity and Mean
Blood Glucose
Multilevel models were conducted to test the first hypotheses that higher levels of
DSS and GS severity would be related to higher MBG values. Results of all models can
be found in Table 5. Increased within-subjects fluctuations in daily DSS severity were
associated with higher daily MBG values. Results indicated that for every 1-point
increase in diabetes-specific stress severity, MBG was higher by 9.44 mg/dl. Conversely,
between-subjects differences in average DSS levels across the measurement period were
not associated with daily MBG values. Similarly, neither within-subjects fluctuations in
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daily GS severity nor between-subjects differences in average GS levels were associated
with daily MBG values. Thus, Hypothesis 1a was supported, but Hypotheses 1b, 1c, and
1d were not.
Anxiety as a Moderator of the Relationship Between Fluctuations in Daily DiabetesSpecific Stress Severity and Mean Blood Glucose

Given the null results of Hypotheses 1b, 1c, and 1d, only hypothesis 2a was
tested. To test the hypothesis that trait anxiety would moderate the association of
fluctuations in DSS severity with MBG, a moderation model was conducted predicting
MBG. Inconsistent with the hypothesis, trait anxiety did not moderate the relation of
within-subjects fluctuations in daily DSS severity with daily MBG. Individuals’ levels of
trait anxiety did not affect the slope of the relationship between fluctuations in daily DSS
severity and daily MBG levels.
Exploratory Analyses
Although hypotheses focused on the ability of psychosocial variables to predict
daily mean blood glucose values (MBG), exploratory analyses were conducted to
examine relationships between key study variables and standard deviations of daily blood
glucose values (SDBG) given existing research demonstrating that BG variability is a
clinically significant health outcome (Hoffman et al., 2016). Multilevel models were
conducted to test the associations between DSS and GS severity and SDBG. No
significant associations were found between daily SDBG values and within-subjects
fluctuations in daily DSS severity, between-subjects differences in average DSS levels,
within-subjects fluctuations in daily GS severity, or between-subjects differences in
average GS levels. As with MBG, moderation models were run to test the potential
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moderating role of trait anxiety on relationships between stress and SDBG, and none
were found to be significant.
Additionally, multilevel models were conducted to explore the potential additive
effects of fluctuations in both DSS and GS severity on blood glucose levels. There is
some research to suggest that the combination of increases in DSS and GS together might
impact BG outcomes more than either independently (Rechenberg, Whittemore, Holland,
et al., 2017). However, the interaction between fluctuations in DSS and GS severity did
not have a significant impact on daily MBG levels or on daily SDBG levels.
Discussion
The present study explored relationships between daily stress (both general and
diabetes-specific), daily blood glucose levels, and trait anxiety in adolescents with T1D.
Ecological momentary assessment, a relatively new approach to research with
adolescents, was utilized to gather data that allowed for the examination of both betweenand within-subjects processes. This study was also innovative in its use of objective
measures of daily glycemic control (i.e., data uploaded from glucometers or continuous
glucose monitors), and it was the first to explore the potential moderating role of anxiety
symptoms on the relationship between stress severity and daily glycemic control.
Results indicated that within-subjects fluctuations in daily diabetes-specific stress
(DSS) were predictive of daily glycemic control (i.e., mean daily blood glucose levels).
By contrast, between-subjects differences in average levels of DSS across the
measurement period did not play a significant role in predicting mean daily blood
glucose. This suggests that on days when DSS levels are higher than an individual’s own
typical level, glycemic control suffers as a result. However, individuals’ respective
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average levels of DSS do not differentiate their glycemic control. This result highlights
the importance of individual stress management by demonstrating that intraindividual
variability in stress is associated with poorer glycemic control. These findings also
underscore the subjectivity of perceived stress and the extent to which stress is the result
of one’s personal interpretation of a situation and subjective psychosocial conditions
(Lindfors et al., 2017; Schraml et al., 2011). This subjectivity may further explain why
between-subjects differences in average levels of both diabetes-specific and general stress
did not differentiate glycemic control in this sample. However, DSS is distinguished from
GS in predicting glycemic control because at the individual level, atypically high DSS
severity on a given day predisposes adolescents to higher BG levels. Notably, the
directionality of this relationship is unclear. It is possible that high levels of DSS impede
good diabetes management by decreasing adolescents’ ability to complete daily
adherence tasks and thereby worsen glycemic control. It may also be that high blood
glucose levels on a particular day trigger an increase in DSS severity, especially for those
adolescents who are attentive to their BG levels and attempt to maintain good glycemic
control.
Contrary to hypotheses, GS severity was not predictive of daily MBG at either
level of variance. Neither average levels of GS across the measurement period nor daily
fluctuations in GS were related to glycemic control. Existing research on the distinction
between GS and DSS is mixed, and the role of each in predicting diabetes outcomes is
unclear. In accordance with the present findings, Baucom and colleagues (2015) found
that GS severity was not related to daily adherence behaviors or glycemic control (as
quantified by HbA1C), while DSS severity was. Rechenberg and colleagues (2017) also
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examined both types of stress and found that while GS and DSS were each independently
related to diabetes outcomes, when both types of stress were entered into the same model,
GS no longer contributed significantly to glycemic control. However, GS did maintain its
contribution to adherence behaviors. Similarly, Farrell and colleagues (2004) found that
daily GS severity was only associated with glycemic control via adherence behaviors.
Importantly, the present study examined only glycemic control as an objective outcome
and not adherence behaviors. Thus, based on these and prior findings, it may be that GS
plays a role in management behaviors but does not directly impact glycemic control. For
example, experiencing high levels of GS severity may direct adolescents’ attention away
from completing adherence tasks throughout the day, while resulting glycemic control
(i.e., BG levels) is more likely to directly impact (or be impacted by) DSS severity.
Notably, in the present study, average DSS levels across the sample were higher than
those of GS, which is in contrast to some other studies that have found GS more
prevalent in adolescents (Chao et al., 2016). This may be related to the timing of our
study; most of the daily diary data were collected early in the fall, when participants may
have been experiencing relatively low levels of school- and peer-related stress. By
contrast, diabetes-specific stressors (e.g., taking the wrong amount of insulin, forgetting
to check BG levels) are constantly present for these adolescents.
Interestingly, no significant relationships were found between DSS or GS severity
and SDBG. While it is known that glycemic variability (such as SDBG) is related to
significant health outcomes for individuals with T1D (e.g., inflammation and
microvascular complications; Gorst et al., 2015; Hoffman et al., 2016), fewer studies
have examined relationships between SDBG and psychosocial outcomes. Notably, SDBG
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may be a better indicator of individuals’ daily experiences of hyper- and hypoglycemia
than of overall glycemic control and, by extension, chronic diabetes complications.
However, long-term glycemic variability is known as a potential barrier to achieving
optimal glycemic control (McCall & Kovatchev, 2009). It is also important to consider
the fact that participants in this study reported very high rates of diabetes technology use
compared to the general pediatric diabetes population (Miller et al., 2015). This may have
resulted in relatively low levels of glycemic variability over the measurement period,
which could explain the lack of findings regarding SDBG. It is possible that in a sample
with increased glycemic variability, relationships between DSS and SDBG would
emerge. Although the present findings do not provide evidence that daily SDBG is
associated with daily stress in this population, it is important to continue studying
glycemic variability in order to gain a full picture of diabetes control and risks in patient
populations.
Anxiety was not found to play a significant role in the relationship between daily
stress severity and glycemic control. At the correlational level, RCMAS-2 total scores
were related only to average DSS severity. There are several potential explanations for
this. First, it is possible that different subtypes of anxiety would play a more meaningful
role in these relationships. For example, relationships between fear of hypoglycemia
(FOH) and glycemic control are mixed, but FOH is related to poorer quality of life in
both children and their parents (Driscoll et al., 2016). FOH may therefore impact
adolescents’ approach to dealing with daily stressors and subsequent daily BG levels.
Second, it is important to highlight the distinction between trait and state anxiety. Trait
anxiety refers to an individual’s general level of anxiety (which was measured in this
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study), while state anxiety refers to in-the-moment anxiety levels. Specifically, the
RCMAS-2 asks respondents to report on whether items are “true of you,” as opposed to
asking about their current state or their feelings in a given situation (Reynolds &
Richmond, 2008). Previous studies examining anxiety in adolescents with T1D have
found that while trait anxiety is related to BGM frequency, state anxiety is related to both
BGM frequency and glycemic control (i.e., HbA1c; Herzer & Hood, 2010). Hilliard and
colleagues (2011) also found that state anxiety levels were significantly related to HbA1C;
trait anxiety levels were not measured in this study. Thus, it is possible that trait anxiety
affects daily adherence tasks but is not significantly related to objective outcomes such as
BG levels or HbA1C. In a recent review of anxiety in youth with T1D, Rechenberg and
colleagues (2017) proposed that trait anxiety is related to FOH and hypervigilance of
physiological symptoms, while state anxiety is more closely related to outcomes
including HbA1C and BGM frequency. Future research incorporating state anxiety into
daily diary surveys, instead of assessing trait anxiety at baseline, may illuminate this
relationship further.
It is also important to consider ways in which the timing of measure
administration may have impacted participants’ scores. Although RCMAS-2 scores
should yield generic levels of trait anxiety, it is possible that anxiety symptoms were
underreported given that participants were in a relatively low-stress camp environment
when they completed the measure. As noted above, RCMAS-2 instructions do not
indicate a specific reporting period, but instead the instructions ask participants whether
or not each item is true of them. Adolescents have particular difficulty accurately
reporting symptoms when compared to adults, especially when they are asked to estimate
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their experiences over an extended or unspecified period (Kamphaus & Frick, 2005).
Participants may have had difficulty estimating their anxiety symptoms while in a
pleasant and stress-free environment, making them more likely to rely on cognitive
heuristics to respond to items (Margetts et al., 2003). RCMAS-2 total T-scores in the
present study were broadly unremarkable or subclinical in nature. Data on rates of
clinical anxiety in this population are mixed; it is widely accepted that youth with T1D
demonstrate higher rates of anxiety symptoms than their health peers, but regarding
“clinically significant” scores, threshold cutoffs are inconsistent across studies
(Buchberger et al., 2016). Thus, it is difficult to say how this sample compares to others
regarding anxiety symptoms endorsed, but it is feasible that completing the measure
while at camp depressed scores somewhat.
Lastly, it is worth noting that moderation analyses involving anxiety scores were
likely underpowered to detect significance, given that a priori power analyses were
conducted for the analyses proposed in Hypothesis 1. Therefore, it may be the case that a
larger sample size would yield significant relationships between anxiety and other key
study variables.
Taken together, the present findings indicate that while fluctuations in daily DSS
severity account for some variability in daily MBG levels, there is more to the equation
than was accounted for in this study. An important factor to consider, and one that was
not measured here, is the role of individual coping styles in response to stressors. Existing
research on coping styles in adolescents with T1D has revealed differences in diabetes
outcomes based on individual coping styles. Broadly, avoidant (or emotion-focused)
coping are related to poorer glycemic control as compared to approach (or problem-
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focused) coping (Delamater et al., 1987; Graue et al., 2004). Jaser and White (2011)
described three distinct coping strategies: primary control engagement (including
problem-solving and emotional expression), secondary control engagement (including
acceptance or cognitive restructuring), and disengagement (including withdrawal or
denial). Primary control coping strategies were associated with the highest quality of life
and best glycemic control. Importantly, secondary control coping was also associated
with better glycemic control (as compared to disengagement), suggesting that secondary
control may still be helpful for adolescents given that there are some aspects of diabetes
that cannot be handled with problem-solving. In these cases, acceptance or cognitive
restructuring appears to be adaptive. Disengagement was consistently associated with
poor glycemic control.
Coping styles may thus be an important intermediate factor in the relationship
between diabetes-specific stress and glycemic control and may explain why in our study,
stress severity alone did not account for variations in daily BG levels. One study found
that adolescents who perceive more diabetes-related distress also utilize avoidant coping
styles, which results in poorer self-management and subsequently poorer HbA1C
(Iturralde et al., 2017). Maladaptive coping strategies, and particularly passive coping,
have also been linked to low levels of resilience in this population (Yi-Frazier et al.,
2015). This suggests that proactive problem-solving is the optimal approach when
individuals encounter diabetes-related stressors. Additionally, low-income and minority
racial/ethnic status have been linked to avoidant coping strategies in this population,
suggesting that chronic stress experienced by these individuals may interfere with their
ability to take a problem-focused approach to diabetes management (Jaser et al., 2012).
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Thus, the relationship between diabetes-specific stress, coping strategies, and glycemic
control of adolescents with T1D is an important area for future study.
Notably, age at diagnosis was a significant predictor of BG levels (both MBG and
SDBG) in all the models reported in this paper. Younger age at diagnosis was
consistently associated with higher MBG and SDBG (i.e., poorer glycemic control). This
finding comports with existing research demonstrating poorer diabetes management and
self-care behaviors in adolescents with longer T1D diagnosis duration as compared to
adolescents diagnosed more recently (Austin et al., 2011; Chao et al., 2014). The present
results underscore the importance of considering duration of diagnosis when estimating
trajectories of glycemic control across adolescence.
The present findings must be interpreted in the context of the study’s limitations.
First, we did not obtain HbA1C values for participants, given that we will not have access
to their medical records. Research with individuals with T1D often includes HbA1C
values as measures of long-term glycemic control. We are therefore unable to draw
conclusions about how these daily psychosocial processes and BG measures relate to
glycemic control over a longer period of time. In future studies, it would be valuable to
measure both daily BG levels using CGMs or glucometers and HbA1C levels
corresponding to the measurement period. This would allow researchers to explore how
these daily processes contribute to long-term glycemic control in this population.
Additionally, as mentioned previously, the size of the present sample was likely
not large enough to detect meaningful relationships in our moderation analyses. In order
to be confident about the findings of these analyses, a larger sample size is warranted. It
is also possible that significant relationships in this study would be furthered strengthened
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by an increase in number of participants. Relatedly, a larger sample size may yield a
more diverse participant population, which could shed light on the differential
experiences of distinct racial or ethnic groups. Existing research has shown that not all
youth with T1D experience stress in the same way. For example, Hispanic/Latinx
emerging adults show a stronger association between DSS and poor glycemic control
than do their non-Hispanic white counterparts, and Hispanic/Latinx individuals show
greater impact of general stress on glycemic control (Butler et al., 2017). A sample with
more racial/ethnic diversity, or one targeting minority populations, would illuminate
potential disparities in daily disease processes between groups. That said, the
racial/ethnic breakdown of the current sample is largely reflective of the demographic
characteristics of youth with T1D in the U.S. (Miller et al., 2015).
Relatedly, it is important to consider the characteristics of the camp-attending
population from which we recruited our sample. As discussed previously, this sample
reported high rates of technology usage (e.g., 93% of participants reported using CGMs).
Given the known diabetes-related benefits of CGM use for those with T1D (i.e.,
improved glycemic control; DeSalvo et al., 2018), it is likely that the present sample had
lower MBG and SDBG than the average adolescent with T1D. There is also evidence that
adolescents who attend diabetes camps are more involved in their diabetes care, and have
more involved families, than the average adolescent with T1D (Chae et al., 2014). This
may have impacted analyses by limiting the variability of BG outcome variables, and also
limits the generalizability of the present results. Thus, it would be valuable to replicate
the present study with a sample that is more representative of the general population of
adolescents with T1D or a higher risk sample (e.g., adolescents with chronically high

42
HbA1C levels or those with low rates of technology use) to determine whether similar or
different associations between diabetes-specific stress and glycemic control are present.
Finally, as with many studies using data of this nature, we are unable to draw
conclusions of causality between daily diabetes-specific stress and glycemic control. This
is due both to the fact that this study was not experimental in nature and to the fact that
we could not establish temporal precedence of stress versus BG values. It is possible that
on a given day, higher BG levels triggered diabetes-specific stress in participants; equally
plausible, however, is the possibility that diabetes-specific stressors impacted
participants’ management of their BG and resulted in higher MBG values. Future
research on daily disease management processes might include multiple daily
measurement points, which could yield data that exhibit the unfolding of a temporal
process. The constant and intensive nature of diabetes management calls for a close
examination of causal processes between psychosocial and disease processes.
Implications
Despite its limitations, the present study offers a meaningful contribution to the
literature on daily processes of adolescents’ management of T1D. The association
between fluctuations in daily diabetes-specific stress and same-day glycemic control
highlights the need for clinicians to focus on bolstering adolescents’ adaptive responses
to daily disease-related stressors. Healthcare providers may incorporate interventions
targeting coping and stress management that are feasible for adolescents to use daily.
There have been some explorations of interventions to target DSS in individuals with
T1D. DSS levels improved following multisystemic therapy (MST) with adolescents with
chronically poorly controlled T1D (Ellis et al., 2005), although it is important to note that
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MST is a relatively intensive and costly intervention and therefore not feasible for many
T1D patients to engage in. Ellis and colleagues (2018) have recently conducted an initial
exploration of mindfulness-based stress reduction aimed at improving DSS in emerging
adults, although results were preliminary, and additional research is warranted.
Researchers in this area have suggested lower cost strategies to help adolescents
manage DSS, including resilience-building interventions, given that resilience is
associated with lower levels of diabetes distress and improved quality of life in
adolescents with T1D (Yi-Frazier et al., 2015). Maladaptive coping styles are likely a
meaningful point of clinical intervention, given existing research demonstrating links
between stress, coping, and glycemic control in adolescents with T1D (Iturralde et al.,
2017; Jaser & White, 2011). Adolescents who use approach coping skills are more likely
to continue to engage in diabetes management behaviors in the face of stressors.
Teaching adolescents to use proactive problem-solving approaches when they encounter
diabetes-specific stressors may bolster their ability to handle such stressors and improve
their ability to maintain good glycemic control despite stressors. Brief stress management
interventions (e.g., diaphragmatic breathing, mindfulness, and relaxation) may be
especially relevant to these adolescents, as these are strategies that can easily be
incorporated into their daily lives. Additionally, it is important to consider adolescents’
life experiences when targeting optimal diabetes management. Low-income and minority
youth may require additional support with managing diabetes stress, especially depending
on how they cope with poverty and discrimination (Jaser et al., 2012). Culturally relevant
interventions are also warranted to bolster coping in an effective manner that
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encompasses holistic considerations of the individual and their environment (Yang et al.,
2019).
Relatedly, findings of the current study highlight the importance of distinguishing
between perceived GS versus DSS when planning interventions for individual
adolescents. High levels of GS may call for generic stress management skills for schooland peer-related stress while promoting good diabetes management in a busy schedule.
Adolescents with higher levels of DSS may benefit instead from interventions targeting
thoughts and behaviors regarding diabetes management tasks. For example, it may be
valuable to discuss strategies for checking BG levels and dosing appropriately for food in
social situations where youth may feel embarrassed.
Lastly, the use of EMA methodology in this study to collect intensive longitudinal
data provides further support that such methods are feasible for use with adolescents and
can provide meaningful results. Compared to our pilot testing, approximately the same
percentage of participants agreed to complete daily diaries following camp, and a much
larger percentage of those participants completed BG uploads to Tidepool®. This
increase may have been due to the introduction of incentives, and it is possible that
additional incentives would boost participant engagement even further. Researchers
should continue to develop and utilize EMA designs to further advance the literature on
psychosocial correlates of disease outcomes in youth with chronic illnesses.
Conclusions
The present study utilized innovative methods to collect intensive longitudinal
data, which allowed for the examination of both between- and within-subjects variance in
daily stressors. Notably, results revealed distinctions in the predictive roles of average
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DSS severity versus daily fluctuations in DSS severity. These findings highlight the
importance of examining both between- and within-person psychosocial processes in
individuals with T1D in order to fully understand the mechanisms underlying disease
management. These data allow us to clarify which daily dynamics and which trait-level
differences play meaningful roles in daily health behaviors and outcomes. The current
findings provide further evidence, in accordance with prior studies (e.g., Berg et al.,
2017; Lansing et al., 2016), that intra- and interindividual processes are often distinct and
differentially associated with medical outcomes for youth with T1D. Additionally,
objective BG data were collected to quantify glycemic control, while other studies of this
nature have relied on self-report data. Our results demonstrating the link between
fluctuations in daily DSS severity with concurrent MBG levels provide additional support
for the need to identify adolescents’ diabetes-related stressors and implement
interventions aimed at daily stress management. By focusing on both intra- and
interindividual processes in this population, the present study enhances our understanding
of adolescents’ daily psychosocial functioning and how it relates to a consequential
diabetes outcome, daily blood glucose levels. Continued development and improvement
of brief, feasible interventions to help adolescents maintain optimal glycemic control
despite inevitable stressors will enable individuals with T1D to thrive.
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Table 1
EMA Studies of Adolescents with Type 1 Diabetes
EMA
Frequency
& Duration

Age
Range

Reminders

Incentives

Online
survey

Once daily,
14 days

17 to 18
years

Nightly
reminders via
text message
or phone call

No information
provided

81.4%

Parental persuasive
strategies, daily
diabetes problems

Online
survey

Once daily,
14 days

10 to 14
years

Nightly
reminders via
phone call

$50 for initial
session, $4 per
completed
diary

91.5%

Berg et al.
(2014)

Adherence behaviors,
self-regulation

Online
survey

Once daily,
14 days

17 to 18
years

Nightly
reminders via
text message
or phone call

$50 for initial
session, $5 per
completed
diary

79.1%

Berg et al.
(2017)

Family context,
adherence behaviors,
adolescent disclosure,
self-regulation

Online
survey

Once daily,
14 days

17 to 18
years

Nightly
reminders via
text message
or phone call

$50 for initial
session, $5 per
completed
diary

80.1%

Borus et al.
(2013)

Adherence behaviors,
social context

Handheld
computer

Four times
daily, 14
days

14 to 18
years

N/A

$100 for
completing
>70% of
diaries

63%
(median)

Authors

Theoretical Constructs

Baucom et
al. (2015)

Depressive symptoms,
stress severity,
adherence behaviors

Berg et al.
(2013)

EMA
Collection
Method

Mean
Response
Rate
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EMA
Frequency
& Duration

Age
Range

Fortenberry Diabetes task
et al.
competence/self(2009)
efficacy, daily affect

Paper/pencil Once daily,
14 days

11 to 16
years

Phone call
reminders
every other
day

$10 for initial
packet, $3 per
completed
diary

85.7%

Fortenberry Negative affect,
et al.
diabetes problems,
perceptions of control,
(2012)
adherence behaviors

Online
survey

10 to 15
years

As-needed
reminder
phone calls

$4 per
completed
diary

91.4%

Hema et al.
(2009)

Daily stressors and
coping strategies

Paper/pencil Once daily,
up to 21
days

8 to 18
years

No
information
provided

No information
provided

14.15
entries

Lansing et
al. (2016)

Self-control, diabetes
negative affect, daily
diabetes problems

Online
survey

Once daily,
14 days

10 to 14
years

Nightly
reminders via
phone call

$50 for initial
session, $4 per
completed
diary

91.5%

Mulvaney
et al.
(2012)

Self-care/adherence
behaviors

Phone calls

Twice daily, 12 to 17
10 days
years

N/A

No information
provided

60.2%

Wiebe et
al. (2018)

Executive function,
Online
diabetes goal planning, survey
adherence behaviors

Once daily,
14 days

Nightly
reminders via
text message
or phone call

$50 for initial
session, $5 per
completed
diary

81.4%

Authors

Theoretical Constructs

EMA
Collection
Method

Once daily,
14 days

17 to 18
years

Reminders

Incentives

Mean
Response
Rate
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Table 2
Demographic Characteristics
Variable

M

SD

Range

n

%

Female

30

68.2

Male

14

31.8

American Indian/Alaska
Native

0

0

Asian

5

9.8

Black/African American

2

3.9

Hispanic or Latina/o

7

13.7

Middle Eastern

1

2.0

Native Hawaiian or Other
Pacific Islander

1

2.0

White or European
American

35

68.6

Other

4

7.8

Uses a pump

41

93.2

Uses a CGM/sensor

42

82.4

Gender

Age at testing (years)

15.35

1.05

13.39 – 17.64

Race (select all that apply)

Age at diagnosis (years)

7.69

3.36

1.50 – 13.50
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Table 3
Descriptive Statistics of Key Study Variables
Variable

M

SD

Range

Mean blood glucose

179.63

51.08

74.67 – 364.83

Standard deviation of blood glucose

62.20

26.51

16.40 – 189.13

General stress severity

0.54

0.69

0.0 – 3.6

Diabetes-specific stress severity

0.86

1.17

0.0 – 4.6

Revised Childhood Manifest Anxiety Scale

55.27

8.00

33 - 71

Total T-score
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Table 4
Bivariate Correlations Between Aggregated Key Study Variables
Variable

1

1. General stress severity

--

2

3

4

2. Diabetes-specific stress severity

.68*

--

3. Mean daily BG (MBG)

.24

.25

--

4. Standard deviation of daily BG (SDBG)

.19

.29

.73*

--

5. Revised Childhood Manifest Anxiety
Scale, Total T-scores

.23

.44*

.13

.14

*p < .01
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Table 5
Multilevel Models Predicting Mean Daily Blood Glucose Levels
Variable

B

SE

t

95% CI

Daily Diabetes-Specific Stress (DSS) Predicting MBG
Intercept

243.12

16.92

14.37***

206.58 – 279.66

Intraindividual (Level 1)
Day

0.68

1.44

0.47

-2.18 – 3.53

Fluctuations in Daily DSS

9.44

4.50

2.10*

0.0 – 18.89

Interindividual (Level 2)
Gender

-20.32

13.52

-1.50

-50.35 – 9.71

Age at diagnosis

-6.40

1.78

-3.59**

-10.40 – -2.40

Mean DSS

12.79

10.07

1.27

-8.85 – 34.43

Daily General Stress (GS) Predicting MBG
Intercept

234.86

15.70

14.96***

203.10 – 266.63

Intraindividual (Level 1)
Day

0.52

1.30

0.40

-2.15 – 3.20

Fluctuations in Daily GS

5.54

5.86

0.95

-7.26 – 18.35

Interindividual (Level 2)
Gender

-14.34

12.07

-1.24

-39.34 – 9.46

Age at diagnosis

-5.78

1.59

-3.64**

-9.01 – -2.55

Mean GS

18.76

11.06

1.70

-3.56 – 41.07

Daily DSS and Anxiety Predicting MBG
Intercept

207.51

54.89

3.78**

95.89 – 319.14

Intraindividual (Level 1)
Day

0.98

1.89

0.52

-2.72 – 4.68

Fluctuations in Daily DSS

70.87

34.16

2.08

-4.88 – 146.62

Fluctuations in Daily
DSS*Anxiety

-1.08

0.60

-1.79

-2.43 – 0.27
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Interindividual (Level 2)
Gender

-18.97

15.21

-1.25

-50.05 – 12.11

Age at diagnosis

-6.93

1.91

-3.63**

-10.85 – -3.01

Mean DSS

9.09

11.15

0.82

-13.60 – 31.77

Anxiety

0.69

0.98

0.71

-1.30 – 2.69

Daily GS and Anxiety Predicting MBG
Intercept

207.39

43.20

4.80***

120.11 – 294.68

Intraindividual (Level 1)
Day
Fluctuations in Daily GS
Fluctuations in Daily
GS*Anxiety

0.47

1.27

0.37

-2.16 – 3.09

-49.43

37.42

-1.32

-130.54 – 31.68

0.97

0.65

1.49

-0.47 – 2.41

Interindividual (Level 2)
Gender

-18.12

12.73

-1.42

-43.78 – 7.54

Age at diagnosis

-5.33

1.54

-3.45**

-8.45 – -2.21

Mean GS

19.72

10.69

1.84

-1.80 – 41.24

Anxiety

0.48

0.77

0.63

-1.07 – 2.04

*p < .05, **p < .01, ***p < .001
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Figure 1
Fluctuations in Diabetes-Specific Stress Predict Daily MBG, While Mean DiabetesSpecific Stress Does Not

Mean DiabetesSpecific Stress

12.79 (10.07)

Mean Daily
Blood Glucose
Fluctuations in
Diabetes-Specific
Stress

9.44* (5.40)

Note. Covariates included in these models are discussed in the text and presented in Table
5; they are not included here to reduce complexity in the figures.
*p < .05.
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Appendix A
Revised Children’s Manifest Anxiety Scale – Second Edition
Directions: The sentences on the page tell how some people think and feel about
themselves. Read each sentence carefully, and then circle the Letter that shows your
answer. Select Yes if you think the sentence is true about you. Select No if you think it is
not true about you. Give an answer for every sentence, even if it is hard to choose one
that fits you. There are no right or wrong answers. Only you can tell us how you think
and feel about yourself. Remember, after you read each sentence; ask yourself “Is this
true about me?” If it is, select Yes. If it is not, select No.
1. I have trouble making up my mind.
2. I get nervous when things do not go the right way for me.
3. Others seem to do things easier than I can.
4. I like everyone I know.
5. Often I have trouble getting my breath.
6. I worry a lot of the time.
7. I feel bad if people laugh at me.
8. I am afraid of a lot of things.
9. I am always kind.
10. I get mad easily.
11. I worry what my parents will say to me.
12. I feel that others do not like the way I do things.
13. I am afraid to give a talk to my class.
14. I always have good manners.
15. It is hard for me to get to sleep at night.
16. I worry about what other people think of me.
17. I feel alone even when there are people with me.
18. I get teased at school.
19. I am always good.
20. Often I feel sick in my stomach.
21. My feelings get hurt easily.
22. My hands feel sweaty.
23. I worry about making mistakes in front of people.
24. I am always nice to everyone.
25. I am tired a lot.
26. I worry about what is going to happen.
27. Other people are happier than I am.
28. I am afraid to speak up in a group.
29. I tell the truth every single time.
30. I have bad dreams.
31. I feel someone will tell me I do things the wrong way.
32. I get angry sometimes.
33. I worried about being called on in class.

YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES

NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
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34. I wake up scared sometimes.
35. I worry when I go to bed at night.
36. It is hard for me to keep my mind on my schoolwork.
37. I sometimes say things I should not say.
38. I fear other kids will laugh at me in class.
39. I worry about someone beating me up.
40. I wiggle in my seat a lot.
41. I am nervous.
42. A lot of people are against me.
43. I have told a lie.
44. I often worry about something bad happening to me.
45. I fear other people will laugh at me.
46. I have too many headaches.
47. I worry that others do not like me.
48. I get nervous around people.
49. I worry about saying something dumb.

YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
YES

NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
NO
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Appendix B
Demographics Survey
1. What is your date of birth? __________
2. Do you have type 1 diabetes?

Yes

No

3. How old were you when you were diagnosed with type 1 diabetes? __________
a. Do you know the date of your diagnosis?___________________
4. What is your gender? _______________
5. What grade will you be in this fall?
6. What is your race/ethnicity? (Select one or more responses)
£ American Indian/Alaska Native
£ Asian
£ Black or African American
£ Hispanic or Latina/o
£ Middle Eastern
£ Native Hawaiian or Other Pacific Islander
£ White or European American
£ Other
7. Do you use a pump?
a. Yes – what brand? __________
b. No
8. Do you use a CGM/sensor?
a. Yes – what brand? __________
b. No
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Appendix C
Daily Stress Survey
Think about if each of these things has happened to you today. Select YES or NO for
each item. For each item you say YES to, select how stressful it was for you today. For
the first five items, if you say YES, select how much this event was related to your
diabetes.
Argument or
disagreement
with someone

If you said YES: How stressful was this today?
1
2
3
4
5
Not at all
A little
Somewhat
Very
As stressful
stressful
stressful
stressful
stressful
as it can get

YES
NO

Problem with
school or
schoolwork

If you said YES: How much was this event related to your diabetes?
1
2
3
4
5
Not at all
A little
Somewhat Very much Completely

If you said YES: How stressful was this today?
1
2
3
4
5
Not at all
A little
Somewhat
Very
As stressful
stressful
stressful
stressful
stressful
as it can get

YES
NO

Problem with
work or
chores

If you said YES: How much was this event related to your diabetes?
1
2
3
4
5
Not at all
A little
Somewhat Very much Completely

If you said YES: How stressful was this today?
1
2
3
4
5
Not at all
A little
Somewhat
Very
As stressful
stressful
stressful
stressful
stressful
as it can get

YES
NO

If you said YES: How much was this event related to your diabetes?
1
2
3
4
5
Not at all
A little
Somewhat Very much Completely
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Having to deal
with other
people’s
problems
YES
NO

Problem
related to
where you
live or things
you own
YES
NO

Problem
with high or
low blood
sugar

1
Not at all
stressful

If you said YES: How stressful was this today?
2
3
4
5
A little
Somewhat
Very
As stressful
stressful
stressful
stressful
as it can get

If you said YES: How much was this event related to your diabetes?
1
2
3
4
5
Not at all
A little
Somewhat Very much Completely

1
Not at all
stressful

If you said YES: How stressful was this today?
2
3
4
5
A little
Somewhat
Very
As stressful
stressful
stressful
stressful
as it can get

If you said YES: How much was this event related to your diabetes?
1
2
3
4
5
Not at all
A little
Somewhat Very much Completely

If you said YES: How stressful was this today?
1
2
3
4
5
Not at all
A little
Somewhat
Very
As stressful
stressful
stressful
stressful
stressful
as it can get

YES
NO
Forgetting
or skipping a
blood
glucose test
YES

If you said YES: How stressful was this today?
1
2
3
4
5
Not at all
A little
Somewhat
Very
As stressful
stressful
stressful
stressful
stressful
as it can get
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NO
Taking the
wrong
amount of
insulin

1
Not at all
stressful

If you said YES: How stressful was this today?
2
3
4
5
A little
Somewhat
Very
As stressful
stressful
stressful
stressful
as it can get

YES
NO
Feeling bad
because of
your
diabetes

If you said YES: How stressful was this today?
1
2
3
4
5
Not at all
A little
Somewhat
Very
As stressful
stressful
stressful
stressful
stressful
as it can get

YES
NO
Problem
with pump
or
continuous
glucose
monitor
YES
NO

If you said YES: How stressful was this today?
1
2
3
4
5
Not at all
A little
Somewhat
Very
As stressful
stressful
stressful
stressful
stressful
as it can get

